Home > Research > Publications & Outputs > Market competition in health care markets in Th...

Links

Text available via DOI:

View graph of relations

Market competition in health care markets in The Netherlands: some lessons for England?

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

Market competition in health care markets in The Netherlands: some lessons for England? / Den Exter, Andre; Guy, Mary.
In: Medical Law Review, Vol. 22, No. 2, 01.03.2014, p. 255-273.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

APA

Vancouver

Den Exter A, Guy M. Market competition in health care markets in The Netherlands: some lessons for England? Medical Law Review. 2014 Mar 1;22(2):255-273. doi: 10.1093/medlaw/fwu009

Author

Den Exter, Andre ; Guy, Mary. / Market competition in health care markets in The Netherlands : some lessons for England?. In: Medical Law Review. 2014 ; Vol. 22, No. 2. pp. 255-273.

Bibtex

@article{5997f45342cf47188a0827bf72a1abd5,
title = "Market competition in health care markets in The Netherlands: some lessons for England?",
abstract = "This article seeks to establish what lessons might be available to the English health care sector following enactment of the Health and Social Care Act 2012 from the Dutch experience of introducing market competition into health care via a mandatory health insurance scheme implemented by for-profit insurance companies. The existence of the Beveridge NHS model in England, and a Bismarckian insurance system in The Netherlands perhaps suggest that a comparison of the two countries is at best limited, and reinforced by the different Enthoven-inspired competitive models each has adopted. However, we contend that there are positive and negative issues arising from introducing competition into health care—, e.g. concerns about equity and benefits of efficiencies—which go beyond national boundaries and different systems and reflect the global paradigm shift towards the use of market forces in previously non-market areas such as health. The article examines the situation in England following the HSCA 2012 and The Netherlands following the 2006 reforms before analysing two areas of common ground: the focus in both countries on competition on quality (as opposed to price) and integrated care, which is assuming ever greater significance. We suggest that our combined insights (as a health lawyer and competition lawyer respectively) coupled with a comparative approach create a novel contribution to current calls for a wider public debate about the real role of markets in health care over and above simple characterisation as a force for good or bad.",
keywords = "English NHS , Health and Social Care Act 2012, Health Care Regulation, Health Insurance, Monitor , The Netherlands",
author = "{Den Exter}, Andre and Mary Guy",
year = "2014",
month = mar,
day = "1",
doi = "10.1093/medlaw/fwu009",
language = "English",
volume = "22",
pages = "255--273",
journal = "Medical Law Review",
issn = "0967-0742",
publisher = "Oxford University Press",
number = "2",

}

RIS

TY - JOUR

T1 - Market competition in health care markets in The Netherlands

T2 - some lessons for England?

AU - Den Exter, Andre

AU - Guy, Mary

PY - 2014/3/1

Y1 - 2014/3/1

N2 - This article seeks to establish what lessons might be available to the English health care sector following enactment of the Health and Social Care Act 2012 from the Dutch experience of introducing market competition into health care via a mandatory health insurance scheme implemented by for-profit insurance companies. The existence of the Beveridge NHS model in England, and a Bismarckian insurance system in The Netherlands perhaps suggest that a comparison of the two countries is at best limited, and reinforced by the different Enthoven-inspired competitive models each has adopted. However, we contend that there are positive and negative issues arising from introducing competition into health care—, e.g. concerns about equity and benefits of efficiencies—which go beyond national boundaries and different systems and reflect the global paradigm shift towards the use of market forces in previously non-market areas such as health. The article examines the situation in England following the HSCA 2012 and The Netherlands following the 2006 reforms before analysing two areas of common ground: the focus in both countries on competition on quality (as opposed to price) and integrated care, which is assuming ever greater significance. We suggest that our combined insights (as a health lawyer and competition lawyer respectively) coupled with a comparative approach create a novel contribution to current calls for a wider public debate about the real role of markets in health care over and above simple characterisation as a force for good or bad.

AB - This article seeks to establish what lessons might be available to the English health care sector following enactment of the Health and Social Care Act 2012 from the Dutch experience of introducing market competition into health care via a mandatory health insurance scheme implemented by for-profit insurance companies. The existence of the Beveridge NHS model in England, and a Bismarckian insurance system in The Netherlands perhaps suggest that a comparison of the two countries is at best limited, and reinforced by the different Enthoven-inspired competitive models each has adopted. However, we contend that there are positive and negative issues arising from introducing competition into health care—, e.g. concerns about equity and benefits of efficiencies—which go beyond national boundaries and different systems and reflect the global paradigm shift towards the use of market forces in previously non-market areas such as health. The article examines the situation in England following the HSCA 2012 and The Netherlands following the 2006 reforms before analysing two areas of common ground: the focus in both countries on competition on quality (as opposed to price) and integrated care, which is assuming ever greater significance. We suggest that our combined insights (as a health lawyer and competition lawyer respectively) coupled with a comparative approach create a novel contribution to current calls for a wider public debate about the real role of markets in health care over and above simple characterisation as a force for good or bad.

KW - English NHS

KW - Health and Social Care Act 2012

KW - Health Care Regulation

KW - Health Insurance

KW - Monitor

KW - The Netherlands

U2 - 10.1093/medlaw/fwu009

DO - 10.1093/medlaw/fwu009

M3 - Journal article

VL - 22

SP - 255

EP - 273

JO - Medical Law Review

JF - Medical Law Review

SN - 0967-0742

IS - 2

ER -